Patent · US Active

Engineered heterodimeric proteins

US11685776B2 · kind B2 · utility

0Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 1, 2018
Grant dateJun 27, 2023
Priority date
Expiry dateOct 22, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/66
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides heterodimeric antibodies and fragments thereof and methods for their preparation, wherein the pairing of heavy and light chains has been improved. Interface residues were mutated such that each light chain strongly favoured its cognate heavy chain when two different heavy chains and two different light chains were co-transfected and co-expressed in the same cell to assemble a functional, heterodimeric antibody or fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.